Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
207,440,936
-
Number of holders
-
164
-
Total 13F shares, excl. options
-
73,478,005
-
Shares change
-
+6,663,175
-
Total reported value, excl. options
-
$457,748,937
-
Value change
-
+$39,215,603
-
Put/Call ratio
-
24%
-
Number of buys
-
95
-
Number of sells
-
-63
-
Price
-
$6.23
Significant Holders of Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) as of Q4 2022
213 filings reported holding ESPR - Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q4 2022.
Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) has 164 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 73,478,005 shares
of 207,440,936 outstanding shares and own 35% of the company stock.
Largest 10 shareholders include WASATCH ADVISORS INC (6,848,378 shares), BlackRock Inc. (5,509,187 shares), Meditor Group Ltd (4,468,835 shares), Bellevue Group AG (4,330,264 shares), VANGUARD GROUP INC (4,260,464 shares), Deep Track Capital, LP (4,000,000 shares), Balyasny Asset Management LLC (3,429,137 shares), BRAIDWELL LP (3,393,405 shares), Point72 Asset Management, L.P. (2,277,000 shares), and MILLENNIUM MANAGEMENT LLC (2,226,809 shares).
This table shows the top 164 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.